The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca “Covishield” and Bharat Biotech “Covaxin” vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca’s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use.
About Covaxin:
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Important takeaways for all competitive exams:
In 2024, India lost several legendary figures who made remarkable contributions to art, literature, sports,…
Dr. Manmohan Singh, a brilliant economist and statesman, served as the 13th Prime Minister of…
India continues to establish itself as one of the leading global economies in 2024, with…
Indian public sector banks (PSBs) have reported strong profitability, with a 25% increase in net…
Nvidia has recently announced the launch of its Jetson Orin Nano Super Generative AI supercomputer,…
Osamu Suzuki, the long-serving chairman and CEO of Suzuki Motor Corporation, passed away at the…